15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27774126	95	Exploring	University of California San Francisco
23562062	4	Arylsulfonamide pyrimidines as VLA-4 antagonists.	Elan Pharmaceuticals
17387018	74	Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization.	Pfizer
16298127	80	Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists.	Pfizer
15006384	179	Synthesis of cinnamic acids and related isosteres as potent and selective alpha v beta 3 receptor antagonists.	Pfizer
14698164	39	Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds.	Pharmaceutical Research Institute
31999923	16	Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations.	Pliant Therapeutics
10406646	15	Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.	Smithkline Beecham Pharmaceuticals
31381331	70	Profile of a Highly Selective Quaternized Pyrrolidine Betaine ?	Glaxosmithkline Medicines Research Centre
24568695	76	Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.	University of Bradford
30215258	228	Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic ?	University of Strathclyde